UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Significant Regional Differences in Antibiotic Use Across 576 US Hospitals and 11 701 326 Adult Admissions, 2016–2017

Clinical infectious diseases, 2021-07, Vol.73 (2), p.213-222

2021

Volltextzugriff (PDF)

Measurement of Adult Antibacterial Drug Use in 130 US Hospitals: Comparison of Defined Daily Dose and Days of Therapy

Clinical infectious diseases, 2007-03, Vol.44 (5), p.664-670

2007

Volltextzugriff (PDF)

Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.1983-1986

2009

Volltextzugriff (PDF)

Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison

Infection control and hospital epidemiology, 2008-03, Vol.29 (3), p.203-211

2008

Volltextzugriff (PDF)

Hospital and Community Fluoroquinolone Use and Resistance in Staphylococcus aureus and Escherichia coli in 17 US Hospitals

Clinical infectious diseases, 2005-08, Vol.41 (4), p.435-440

2005

Volltextzugriff (PDF)

Predicting Hospital Rates of Fluoroquinolone-Resistant Pseudomonas aeruginosa from Fluoroquinolone Use in US Hospitals and Their Surrounding Communities

Clinical infectious diseases, 2004-08, Vol.39 (4), p.497-503

2004

Volltextzugriff (PDF)

Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers

Infection control and hospital epidemiology, 2009-06, Vol.30 (6), p.600-603

2009

Volltextzugriff (PDF)

Antibiogram compliance in University HealthSystem Consortium participating hospitals with Clinical and Laboratory Standards Institute guidelines

American journal of health-system pharmacy, 2012-04, Vol.69 (7), p.598-606

2012

Volltextzugriff (PDF)

Electronically Available Patient Claims Data Improve Models for Comparing Antibiotic Use Across Hospitals: Results From 576 US Facilities

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e4484-e4492

2021

Volltextzugriff (PDF)

Increase in use of vancomycin for Clostridium difficile infection in US hospitals

Infection control and hospital epidemiology, 2010-08, Vol.31 (8), p.867-868

2010

Volltextzugriff (PDF)

Pharmacokinetics of [14C]Abacavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitor, Administered in a Single Oral Dose to HIV-1-Infected Adults: a Mass Balance Study

Antimicrobial Agents and Chemotherapy, 1999-12, Vol.43 (12), p.2855-2861

1999

Volltextzugriff (PDF)

Pharmacokinetic Interaction between Amprenavir and Rifabutin or Rifampin in Healthy Males

Antimicrobial Agents and Chemotherapy, 2001-02, Vol.45 (2), p.502-508

2001

Volltextzugriff (PDF)

Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram

Journal of antimicrobial chemotherapy, 2004-05, Vol.53 (5), p.853-859

2004

Volltextzugriff (PDF)

Trends in antibacterial use in US academic health centers: 2002 to 2006

Archives of internal medicine (1960), 2008-11, Vol.168 (20), p.2254

2008

Volltextzugriff (PDF)

Tolerance and Pharmacokinetic Interactions of Rifabutin and Azithromycin

Antimicrobial Agents and Chemotherapy, 2001-05, Vol.45 (5), p.1572-1577

2001

Volltextzugriff (PDF)

Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital-Onset Clostridium difficile Infection: Implications for Antimicrobial Stewardship

Pharmacotherapy, 2012-08, Vol.32 (8), p.744-754

2012

Volltextzugriff (PDF)

Perceived barriers to scholarship and research among pharmacy practice faculty: survey report from the AACP Scholarship/Research Faculty Development Task Force

American journal of pharmaceutical education, 2009-02, Vol.73 (1), p.17-17

2009

Volltextzugriff (PDF)

Identifying hospital antimicrobial resistance targets via robust ranking

IISE transactions on healthcare systems engineering, 2017-07, Vol.7 (3), p.121-128

2017

Volltextzugriff (PDF)

Antimicrobial formularies: can they minimize antimicrobial resistance?

American journal of health-system pharmacy, 2003-05, Vol.60 (10 Suppl 1), p.S16-S19

Polk, Ronald E

2003

Volltextzugriff (PDF)

Perceived Barriers to Scholarship and Research Among Pharmacy Practice Faculty: Survey Report from the AACP Scholarship/Research Faculty Development Task Force

American journal of pharmaceutical education, 2009, Vol.73 (1), p.1

2009

Volltextzugriff (PDF)

Metabolic Disposition and Pharmacokinetics of [14C]-Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects

Journal of clinical pharmacology, 2001-04, Vol.41 (4), p.386-396

2001

Volltextzugriff (PDF)

Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital‐Onset C lostridium difficile Infection: Implications for Antimicrobial Stewardship

Pharmacotherapy, 2012-08, Vol.32 (8), p.744-754

2012

Volltextzugriff (PDF)

Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital-Onset Clostridium difficile Infection: Implications for Antimicrobial Stewardship : ANTIMICROBIAL STEWARDSHIP

Pharmacotherapy, 2012, Vol.32 (8), p.744-754

2012

Volltextzugriff (PDF)

Case studies in effective formulary management

American journal of health-system pharmacy, 2003, Vol.60

POLK, Ronald E

2003

Volltextzugriff (PDF)

Antimicrobial formularies: Can they minimize antimicrobial resistance?: Case studies in effective formulary management

American journal of health-system pharmacy, 2003, Vol.60, p.S16-S19

POLK, Ronald E

2003

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(72)
Reviews
(1)

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(48)
Humans
(39)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Adult
(20)
Pharmacology. Drug Treatments
(17)
Male
(16)
Surgery
(16)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(15)
Pharmacology & Pharmacy
(14)
Anti-Bacterial Agents - Therapeutic Use
(12)
Authorship
(12)
Clinical Trials As Topic - Standards
(12)
Conflict Of Interest
(12)
Contract Services
(12)
Drug Industry
(12)
Ethics, Professional
(12)
Female
(12)
Infectious Diseases
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Significant Regional Differences in Antibiotic Use Across 576 US Hospitals and 11 701 326 Adult Admissions, 2016–2017

Measurement of Adult Antibacterial Drug Use in 130 US Hospitals: Comparison of Defined Daily Dose and Days of Therapy

Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa

Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison

Hospital and Community Fluoroquinolone Use and Resistance in Staphylococcus aureus and Escherichia coli in 17 US Hospitals

Predicting Hospital Rates of Fluoroquinolone-Resistant Pseudomonas aeruginosa from Fluoroquinolone Use in US Hospitals and Their Surrounding Communities

Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers

Antibiogram compliance in University HealthSystem Consortium participating hospitals with Clinical and Laboratory Standards Institute guidelines

Electronically Available Patient Claims Data Improve Models for Comparing Antibiotic Use Across Hospitals: Results From 576 US Facilities

Increase in use of vancomycin for Clostridium difficile infection in US hospitals

Pharmacokinetics of [14C]Abacavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitor, Administered in a Single Oral Dose to HIV-1-Infected Adults: a Mass Balance Study

Pharmacokinetic Interaction between Amprenavir and Rifabutin or Rifampin in Healthy Males

Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram

Trends in antibacterial use in US academic health centers: 2002 to 2006

Tolerance and Pharmacokinetic Interactions of Rifabutin and Azithromycin

Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital-Onset Clostridium difficile Infection: Implications for Antimicrobial Stewardship

Perceived barriers to scholarship and research among pharmacy practice faculty: survey report from the AACP Scholarship/Research Faculty Development Task Force

Identifying hospital antimicrobial resistance targets via robust ranking

Antimicrobial formularies: can they minimize antimicrobial resistance?

Perceived Barriers to Scholarship and Research Among Pharmacy Practice Faculty: Survey Report from the AACP Scholarship/Research Faculty Development Task Force

Metabolic Disposition and Pharmacokinetics of [14C]-Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects

Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital‐Onset C lostridium difficile Infection: Implications for Antimicrobial Stewardship

Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital-Onset Clostridium difficile Infection: Implications for Antimicrobial Stewardship : ANTIMICROBIAL STEWARDSHIP

Case studies in effective formulary management

Antimicrobial formularies: Can they minimize antimicrobial resistance?: Case studies in effective formulary management

Suchergebnisse filtern